Posted on 05/07/2003 4:26:33 PM PDT by per loin
7 May 2003
Case fatality ratio
WHO has today revised its initial estimates of the case fatality ratio of SARS. The revision is based on an analysis of the latest data from Canada, China, Hong Kong SAR, Singapore, and Viet Nam.
On the basis of more detailed and complete data, and more reliable methods, WHO now estimates that the case fatality ratio of SARS ranges from 0% to 50% depending on the age group affected, with an overall estimate of case fatality of 14% to 15%.
The likelihood of dying from SARS in a given area has been shown to depend on the profile of the cases, including the age group most affected and the presence of underlying disease. Based on data received by WHO to date, the case fatality ratio is estimated to be less than 1% in persons aged 24 years or younger, 6% in persons aged 25 to 44 years, 15% in persons aged 45 to 64 years, and greater than 50% in persons aged 65 years and older.
A case fatality ratio measures the proportion of all people with a disease who will die from the disease. In other words, it measures the likelihood that a disease will kill its host, and is thus an important indicator of the severity of a disease and its significance as a public health problem. The likelihood that a person will die of SARS could be influenced by factors related to the SARS virus, the route of exposure and dose (amount) of virus, personal factors such as age or the presence of another disease, and access to prompt medical care.
Many factors complicate efforts to calculate a case fatality ratio while an outbreak is still evolving. Deaths from SARS typically occur after several weeks of illness. Full recovery may take even longer. While an epidemic is still evolving, only some of the individuals affected by the disease will have died or recovered. Only at the end of an epidemic can an absolute value be calculated, taking into account total deaths, total recoveries and people lost to follow-up. Calculating case fatality as the number of deaths reported divided by the number of cases reported irrespective of the time elapsed since they became ill gives an underestimate of the true case fatality ratio.
One method of overcoming this difficulty is to calculate the case fatality ratio using only those cases whose final outcome â died or recovered â is known. However, this method, when applied before an outbreak is over, gives an overestimate because the average time from illness onset to death for SARS is shorter than the average time from illness onset to recovery.
With these methods, estimates of the case fatality ratio range from 11% to 17% in Hong Kong, from 13% to 15% in Singapore, from 15% to 19% in Canada, and from 5% to 13% in China.
A more accurate and unbiased estimation of case fatality for SARS can be obtained with a third method, survival analysis. This method relies on detailed individual data on the time from illness onset to death or full recovery, or time since illness onset for current cases. Using this method, WHO estimates that the case fatality ratio is 14% in Singapore and 15% in Hong Kong.
In Viet Nam, where SARS has been contained and measurement is more straightforward, case fatality was comparatively low, at 8%. One explanation for this is the large number of total cases that occurred in younger, previously healthy health care workers.
Incubation period
WHO has also reviewed estimates of the incubation period of SARS, using individual case data. On the basis of this review, WHO continues to conclude that the current best estimate of the maximum incubation period is 10 days.
The incubation period, which is the time from exposure to a causative agent to onset of disease, is particularly important as it forms the basis for many recommended control measures, including contact tracing and the duration of home isolation for contacts of probable SARS cases. Knowledge about the incubation period can also help physicians make diagnostic decisions about whether the presenting symptoms and clinical history of a patient point to SARS or to some other disease.
The incubation period can vary from one case to another according to the route by which the person was exposed, the dose of virus received, and other factors, including immune status. Estimates of the incubation period are further complicated by the fact that some patients have had opportunities for multiple exposures to the virus. The particular exposure that caused disease may prove impossible to determine. For these reasons, the most reliable estimates of the incubation period are based on a study of cases having a single documented exposure to a known case.
In todayâs review, WHO has analysed the incubation periods of individuals with well-defined single-point exposures in Singapore, Canada, and Europe. Findings support the original estimate of 10 days as the maximum incubation period.
However, one recently published analysis of data from Hong Kong estimates a longer maximum incubation period in a group of 57 patients. This analysis, which may be significant and important for disease control, will be studied in more detail. The longer incubation period could reflect differences in methodology, specificity of diagnosis, route of transmission, infectious dose, or other factors. Reliable diagnosis â determining that all cases diagnosed as SARS are true cases of the disease â has been particularly difficult to establish in this outbreak, as diagnosis is made based on a set of non-specific symptoms and clinical signs that are seen in several other diseases.
Prompt isolation
WHO continues to recommend the earliest possible isolation of all suspect and probable cases of SARS. A short time between onset of symptoms and isolation reduces opportunities for transmission to others. It also reduces the number of contacts requiring active follow-up, and thus helps relieve some of the burden on health services. In addition, prompt hospitalization gives patients the best chance of receiving possibly life-saving care should their condition take a critical course.
Update on cases and countries
As of today, a cumulative total of 6903 probable SARS cases and 495 deaths has been reported from 29 countries. This represents an increase of 186 new cases and 17 deaths compared with yesterday. The new deaths occurred in China (5), Hong Kong SAR (11) and Taiwan (1).
SARS Mortality Rates [reflects treatment] Based on World Health Organization daily tables (Revised: May 7 pm) |
|||||||
Area | Recoveries to date | Deaths to date | Recent** Death Rate | Active Cases still in Danger | Projected Future Deaths | Projected Cumulative Mortality | |
Hong Kong | 984 | 204 | 19.6% | 466 | 91 | 17.8% | |
Singapore | 150 | 27 | 21.4% | 27 | 6 | 16.2% | |
China | 1487 | 219 | 27.9% | 2854 | 796 | 22.3% | |
Canada | 93 | 22 | 25.0% | 31 | 8 | 20.5% | |
elsewhere [28 countries] |
171 | 23 | 18.0% | 145 | 26 | 14.5% | |
World-wide [all 32 countries] |
2885 | 495 | 3523 | 927 | 20.6% | ||
** ( Deaths in the last 7 days) / ( Deaths + Recoveries in the last 7 days) |
Trend - Active Cases Still in Danger [reflects containment] | |||||||
Date | Hong Kong | Singapore | China | Canada | elsewhere 28 countries |
World-wide all 32 countries |
|
Apr 22 | 874 | 60 | 708 | 61 | 80 | 1783 | |
Apr 23 | 831 | 58 | 968 | 62 | 86 | 2005 | |
Apr 24 | 812 | 55 | 1058 | 58 | 76 | 2059 | |
Apr 25 | 781 | 50 | 1209 | 51 | 78 | 2169 | |
Apr 26 | 774 | 51 | 1346 | 47 | 86 | 2304 | |
Apr 27 (est.) | 738 | 45 | 1415 | 47 | 98 | 2336 | |
Apr 28 | 709 | 39 | 1484 | 47 | 108 | 2387 | |
Apr 29 | 663 | 38 | 1833 | 40 | 108 | 2682 | |
Apr 30 | 641 | 38 | 1969 | 41 | 132 | 2821 | |
May 1 | 604 | 33 | 2117 | 40 | 117 | 2911 | |
May 2 | 563 | 32 | 2246 | 34 | 119 | 2994 | |
May 3 | 544 | 31 | 2375 | 33 | 114 | 3097 | |
May 4 (est.) | 532 | 30 | 2507 | 33 | 125 | 3227 | |
May 5 | 520 | 29 | 2641 | 33 | 135 | 3358 | |
May 6 | 495 | 28 | 2735 | 33 | 132 | 3423 | |
May 7 | 466 | 27 | 2854 | 31 | 145 | 3523 | |
(includes new daily cases... excludes cases resolved by death or recovery) |
Thanks. I hadn't seen that figure. Is it 36 days from contact? or 36 days from diagnosis/hospitalization?
I had thought HK was resolving active cases recently in about 22 days vs 15 days for Singapore/Canada.
It also wouldn't surprise me if the continually degrading fatal cases hang on as long or longer(on average) than those that recover enough to be sent home(on average).
Where again is your detailed chart of stats?
Thanks in advance, FLE
I spent an hour this morning unsuccessfully trying to impart this knowledge to a disruptor on another thread. I guess some people are slow learners. ;-)
Regards.
Now it may be that the differneces between the Free Republic numbers and the WHO numbers are not significant but I wil stick with the Free Republic numbers for now becaus eI seriously question the assumptions the WHO uses to claim that our formula about deaths divided by (recoveries + deaths) overstaes the mortality. However, let me state the simple truth. SARS is a disease with a mortality rate that is between 15% and 24% in the general population. The number of people who are coming down with SARS is growing geometrically.
I think the spread is only geometric in China. The worldwide spread appears to be geometric because more and more the Chinese cases are dominating the numbers.
It would be interesting to know some other factors such as Hepatitis B and Hepatitis C status and some other diseases. The rate of chronic Hepatitis B is 10-20% in SE Asia ---maybe those people are weakened by their cirrhosis and Hepatitis that they die from SARS and others wouldn't get as sick.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.